J0750
HCPCSHiv prep, ftc/tdf 200/300mg
Official HCPCS Level II long descriptor
Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
HCPCS Level II code J0750 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Hiv prep, ftc/tdf 200/300mg
Added to HCPCS: 2024-01-02
Nearby codes in J0
- J0738Hiv prep, inj, lenacapavir
- J0739Hiv prep, inj, cabotegravir
- J0740Cidofovir injection
- J0741Inj, cabote rilpivir 2mg 3mg
- J0742Inj imip 4 cilas 4 releb 2mg
- J0743Cilastatin sodium injection
- J0744Ciprofloxacin iv
- J0745Inj codeine phosphate /30 mg
- J0751Hiv prep, ftc/taf 200/25mg
- J0752Hiv prep, oral lenacapavir
- J0759Inj, clevidipine, 1 mg
- J0770Colistimethate sodium inj
- J0775Collagenase, clost hist inj
- J0780Prochlorperazine injection
- J0791Inj crizanlizumab-tmca 5mg
- J0799Hiv prep, fda approved, noc
Where this code sits
Krasyn Codes for Chrome
Review coding suggestions beside a validated web workflow. Private pilot.
Request pilot accessSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.